What Does the Future Hold for Genomic and Proteomic Analyses in Cancer?
The future looks promising with advancements such as:
Single-Cell Sequencing: Allowing for the study of genetic and proteomic changes at the single-cell level, providing deeper insights into tumor heterogeneity. Artificial Intelligence (AI): Employing AI and machine learning to analyze complex datasets, improving the accuracy and speed of interpretations. Liquid Biopsies: Non-invasive techniques to monitor cancer progression and treatment response using blood samples.
